Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01257958 · ClinicalTrials.gov registry record · Phase 1
Vitamin D Pilot Study in Patients With Multiple Sclerosis
A Phase 1 study of Relapsing Remitting Multiple Sclerosis, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Study location
NCT01257958: Completed Phase 1 study of Relapsing Remitting Multiple Sclerosis, sponsored by University of Wisconsin, Madison.
NCT01257958 is a Phase 1 study of Relapsing Remitting Multiple Sclerosis that has completed, run by University of Wisconsin, Madison. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01257958, a Phase 1 study of Relapsing Remitting Multiple Sclerosis, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1
- Study location
Study Summary
Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.
Conditions Studied
Interventions
- DRUG 19 nor vitamin d
Study Locations (1)
Wisconsin
- UW-Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-02 |
| Est. Completion | 2000-06 |
| Phase | Phase 1 |
What the finished NCT01257958 record still lists
NCT01257958 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Relapsing Remitting Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which 19 nor vitamin d is the first listed.
NCT01257958 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01257958 about?
NCT01257958 is a clinical study titled "Vitamin D Pilot Study in Patients With Multiple Sclerosis". Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.
What is the current status of trial NCT01257958?
This trial is currently completed. It is a Phase 1 study. The study started on 1998-02. Estimated completion is 2000-06.
What conditions does trial NCT01257958 study?
This clinical trial studies the following conditions: Relapsing Remitting Multiple Sclerosis.
What interventions are being tested in trial NCT01257958?
The interventions under investigation include: 19 nor vitamin d (DRUG).
Who is sponsoring clinical trial NCT01257958?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01257958 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Relapsing Remitting Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
WEBCAMS: Walking Exercise for Brain and Cognition in Adults With Multiple Sclerosis
ACTIVE NOT RECRUITING · Phase 1
-
Safety Study of BIIB033 in Subjects With Multiple Sclerosis
COMPLETED · Phase 1
-
Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
RECRUITING
-
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
RECRUITING
-
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
RECRUITING · NA
-
Functional Outcomes From Diets in Multiple Sclerosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia